Trials / Conditions / Ovarian Cancer, Epithelial

Ovarian Cancer, Epithelial

10 registered clinical trials studyying Ovarian Cancer, Epithelial — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithe NCT06640348	Anhui Provincial Hospital	—
Completed	Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizum NCT05585034	Xencor, Inc.	Phase 1
Unknown	Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer NCT05422183	Zhongda Hospital	Phase 2
Recruiting	A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674	Nurix Therapeutics, Inc.	Phase 1
Unknown	A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation NCT04473339	CAI Hongbing	Phase 3
Completed	Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients NCT04537702	Duke University	N/A
Unknown	Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced a NCT03371693	Zhongnan Hospital	Phase 3
Recruiting	Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer NCT03025477	Groupe Hospitalier Diaconesses Croix Saint-Simon	Phase 2
Completed	The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian C NCT02135523	Yonsei University	N/A
Completed	Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors NCT01286987	Pfizer	Phase 1